ERBB2 and breast cancer: Both the prospective and retrospective studies that provided information on healthy lifestyle indices and HER2+ BC molecular subtype showed a statistically significant negative association (HR = 0.70; 95% CI: 0.55, 0.90 and OR = 0.24; 95% CI: 0.09, 0.60, respectively [14,46]), except for one (14).